PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $4.38 and traded as high as $4.53. PetMed Express shares last traded at $4.49, with a volume of 204,635 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, February 11th.

PetMed Express Stock Up 0.4 %

The firm has a 50 day moving average of $4.85 and a 200 day moving average of $4.38. The firm has a market cap of $92.75 million, a price-to-earnings ratio of 449.45 and a beta of 0.70.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. Equities analysts expect that PetMed Express, Inc. will post 0.19 EPS for the current year.

Insider Activity at PetMed Express

In other news, Director Leslie C.G. Campbell acquired 15,000 shares of the stock in a transaction dated Wednesday, December 4th. The stock was purchased at an average cost of $5.38 per share, with a total value of $80,700.00. Following the completion of the purchase, the director now owns 70,000 shares in the company, valued at approximately $376,600. The trade was a 27.27 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Independent Advisor Alliance purchased a new stake in shares of PetMed Express during the 3rd quarter valued at about $106,000. R Squared Ltd purchased a new position in shares of PetMed Express during the fourth quarter valued at approximately $31,000. Virtu Financial LLC bought a new stake in shares of PetMed Express during the fourth quarter valued at approximately $58,000. American Century Companies Inc. increased its holdings in PetMed Express by 15.3% during the fourth quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock valued at $162,000 after buying an additional 4,459 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in PetMed Express by 355.5% in the fourth quarter. JPMorgan Chase & Co. now owns 106,954 shares of the company’s stock worth $516,000 after purchasing an additional 83,473 shares during the last quarter. Institutional investors own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.